Good news, maybe, for men with prostate cancer that has not responded to hormonal treatments: research conducted at the the Clinical Oncology Centre for Early Trials at the Hôpital Européen Georges Pompidou in Paris has revealed that a new drug that targets vitamin D receptors on cancer cells significantly lowered the PSA levels in men with hormone resistent cancer when combined with current therapy. Science Daily reports that 83 percent of patients in the 54-person test group saw their PSA drop by 30 percent or more within three months, and 67 percent saw it drop by 50 percent. The drug, inecalcitol, will now be tested in a larger trial, which is expected to start in the second quarter of 2011.
Health, fitness and lifestyle tips for people over 50 who still like to play hard
Saturday, May 31, 2025
LET ME TRY IT. MY PSA IS 37.5
DAVEGREENIDGE
LET ME TRY IT. MY PSA IS 37.5
DAVEGREENIDGE
This trial is for those with active prostate cancer not those with artifically fueled elevated PSA levels. If the prostate is enlarged (BPH) from Benign Prostatic Hyperplasia, it will release more antigen into the blood stream than a small gland. To lower PSA with this drug serves no purpose because there was no cancer present or additional probability of future cancer. There are 4 main causes of elevated PSA the most common is BPH,secondly is infection such as prostatitus infection present in a male (UTI) or urinary tact infection. 3rd is Prostate Cancer and 4th is Prostate Trauma which includes impact to the male perinium an area located inbetween the Testes and Anus. Also a prstate biopsy will elevate the PSA post biopsy .
If the software is offered for free why would they still impose a tax on it?